Porsche, Deutsche Bank, Thyssenkrupp and Novartis are all moving with Investing.com

Porsche, Deutsche Bank, Thyssenkrupp and Novartis are all moving with Investing.com


© Reuters.

Investing.com – European stocks are moving strongly in early trading on Monday, September 12, 2022. Here are the private stocks performing in early European stock markets:

  • Swiss Re share (SIX:) +0.52 percent: Considering geopolitical tensions, global economic development and climate change, the Swiss insurer expects an increase in insurance demand. Higher risks and increased demand are likely to be reflected in rising tariffs. According to its own estimates, the group expects the insurance market in the area of ​​natural disasters to grow to an amount of about 48 billion dollars in the next four years, from the current figure of 35 billion dollars.
  • Deutsche Bank share (ETR:) +0.66 percent: Deutsche Bank wants to compete with fast-growing online banks with new offers. Germany’s largest financial institution wants to launch an independent digital, software-based offering for clients with investment needs in 2024. This should target people who want their assets professionally managed, want to trade securities online and want to do their banking digital, said Vice Chairman Karl von Rohr to “Handelsblatt”.
  • Participate in Hannover (ETR:) -0.02 percent: In the upcoming negotiations on contract renewals with primary insurers, management is insisting on higher prices. The trend towards higher cost claims makes price increases and better conditions in non-life insurance very important. Rising inflation increases the cost of paying for the damage. In terms of natural disaster covers, this has already been reflected in prices this year, and now other sectors such as car insurance must follow suit.
  • Novartis share (SIX:) +0.61 percent: According to the pharmaceutical company, the drug Cosentyx significantly improved the symptoms of patients with the inflammatory skin disease Hidradenitis Suppurativa in a phase III clinical study. In addition, the drug tislelizumab, which was developed in collaboration with the Chinese company BeiGene, showed efficacy in a phase III study for the initial treatment of patients with advanced liver cancer and was well tolerated.
  • Porsche share (ETR:) +0.72: VW’s sports car subsidiary Porsche wants to be ready for its IPO as soon as possible given the strong interest from investors. Volkswagen (ETR:) wants to list 12.5 percent of the share capital of its Stuttgart subsidiary in early October and thus raise billions.
  • Lonza participate (SIX:) +0.54 percent: Daniel Palmacci will take over as head of the Cell & Gene Division at the pharmaceutical contract manufacturer on November 1 and become a member of the Executive Board. His predecessor Jean-Christophe Hyvert remains head of the Biology Unit.
  • Thyssenkrupp shares (ETR:) +0.75 percent: The industry association BDI has called on the federal government not to think about the effects of the energy crisis, but to focus on its cause. Along with taxes, as well as internet costs can be factored in before companies wind up a big bill in-house. Even companies with low energy consumption, for example two percent of their costs, could not absorb the increase of eight or nine times.

And material from Reuters